CV Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- CV Therapeutics's estimated annual revenue is currently $88.2M per year.
- CV Therapeutics's estimated revenue per employee is $155,000
Employee Data
- CV Therapeutics has 569 Employees.
- CV Therapeutics grew their employee count by -2% last year.
CV Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Facility Technician | Reveal Email/Phone |
2 | Staffing Consultant | Reveal Email/Phone |
CV Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.3M | 21 | 31% | N/A | N/A |
What Is CV Therapeutics?
CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.
keywords:N/A
N/A
Total Funding
569
Number of Employees
$88.2M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35M | 580 | 11% | N/A |
#2 | $133.4M | 593 | N/A | N/A |
#3 | $300M | 599 | 13% | $263.3M |
#4 | $113.1M | 614 | -18% | $747.4M |
#5 | $133.5M | 615 | 28% | $551M |